Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T19:57:11.902Z.
Calculation as of: 2026-10-06T19:57:11.902Z.
Quote observation: 2026-10-06T19:55:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 48f0cd224d3c7dd52ecd2cde696dbbeed4cc913852df97ed5052446ca25b90ee
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$73.10M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$74.90M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$72.60M
Operating Cash Flow Yield
N/A
TTM Avg
0.41%
3Y Avg
0.41%
5Y Avg
0.41%
Market Cap
$75.82M
Operating Cash Flow Yield
28.96%
TTM Avg
26.53%
3Y Avg
15.21%
5Y Avg
15.21%
Market Cap
$75.98M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$70.59M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$76.75M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.72M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hyperfine, Inc. (HYPR) | $73.77M | N/A | N/A | N/A | N/A |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $73.10M | N/A | N/A | N/A | N/A |
| Pulmonx Corporation (LUNG)vs › | $74.90M | N/A | N/A | N/A | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $72.60M | N/A | 0.41% | 0.41% | 0.41% |
| SkinHealth Systems Inc. (SKIN)vs › | $75.82M | 28.96% | 26.53% | 15.21% | 15.21% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $75.98M | N/A | N/A | N/A | N/A |
| Gain Therapeutics, Inc. (GANX)vs › | $70.59M | N/A | N/A | N/A | N/A |
| Outset Medical, Inc. (OM)vs › | $76.75M | N/A | N/A | N/A | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $77.72M | N/A | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $77.73M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
